<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about NPSP</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Tue, 21 May 2013 12:34:52 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=NPSP" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/nps-pharma-incurs-narrower-1q-loss-analyst-blog-cm245977">
      <guid isPermaLink="false">245977</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Oi6bIikTbVI/nps-pharma-incurs-narrower-1q-loss-analyst-blog-cm245977</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>NPS Pharma Incurs Narrower 1Q Loss - Analyst Blog</title>
      <description>NPS Pharmaceuticals, Inc.  (  NPSP  ) reported first  quarter 2013 net loss per share of 9 cents per share, narrower than  the Zacks Consensus Estimate of a loss of 13 cents and the year-ago&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Oi6bIikTbVI" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 14 May 2013 18:23:01 Z</pubDate>
      <a10:updated>2013-05-14T15:09:34Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>CBST</nasdaq:tickers>
      <nasdaq:tickers>CELG</nasdaq:tickers>
      <nasdaq:tickers>LCI</nasdaq:tickers>
      <nasdaq:tickers>NPSP</nasdaq:tickers>
      <nasdaq:tickers>SBS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/nps-pharma-incurs-narrower-1q-loss-analyst-blog-cm245977</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/weekly-cfo-sells-highlight-ko-kkd-pir-npsp-acad-cm237295">
      <guid isPermaLink="false">237295</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c9kAn2T_65g/weekly-cfo-sells-highlight-ko-kkd-pir-npsp-acad-cm237295</link>
      <category>Investing</category>
      <title>Weekly CFO Sells Highlight: KO, KKD, PIR, NPSP, ACAD</title>
      <description>According to  GuruFocus Insider Data  , the largest CFO sells during the past week were: Coca-Cola Co., Krispy Kreme Doughnuts Inc., Pier 1 Imports Inc., NPS Pharmaceuticals Inc. and ARCADIA&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/c9kAn2T_65g" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 16 Apr 2013 20:07:30 Z</pubDate>
      <a10:updated>2013-04-16T17:08:21Z</a10:updated>
      <author>gurujx</author>
      <nasdaq:tickers>ACAD</nasdaq:tickers>
      <nasdaq:tickers>KKD</nasdaq:tickers>
      <nasdaq:tickers>KO</nasdaq:tickers>
      <nasdaq:tickers>NPSP</nasdaq:tickers>
      <nasdaq:tickers>PIR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/weekly-cfo-sells-highlight-ko-kkd-pir-npsp-acad-cm237295</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/nps-pharma-and-takeda-amend-deal-analyst-blog-cm228756">
      <guid isPermaLink="false">228756</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cvQ2K8bOpvg/nps-pharma-and-takeda-amend-deal-analyst-blog-cm228756</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>NPS Pharma and Takeda Amend Deal - Analyst Blog</title>
      <description>NPS Pharmaceuticals, Inc.  (  NPSP  ) and  Takeda Pharmaceutical Company Limited  (  TKPYY  ) recently amended their deal regarding a couple of drugs. Following the amended deal, NPS Pharma&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/cvQ2K8bOpvg" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 20 Mar 2013 03:45:19 Z</pubDate>
      <a10:updated>2013-03-20T00:44:43Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>LCI</nasdaq:tickers>
      <nasdaq:tickers>NPSP</nasdaq:tickers>
      <nasdaq:tickers>TKPYY</nasdaq:tickers>
      <nasdaq:tickers>WX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/nps-pharma-and-takeda-amend-deal-analyst-blog-cm228756</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/midday-market-update-markets-turn-red-dsw-declines-on-downbeat-view-cm228627">
      <guid isPermaLink="false">228627</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WuhEQpWT9Xc/midday-market-update-markets-turn-red-dsw-declines-on-downbeat-view-cm228627</link>
      <category>Investing</category>
      <category>Commodities</category>
      <category>Economy</category>
      <category>International</category>
      <title>Mid-Day Market Update: Markets Turn Red, DSW Declines On Downbeat View</title>
      <description>Midway through trading Tuesday, the Dow traded down 0.26 percent to 14,413.93 while the NASDAQ dropped 0.50 percent to 3,221.50. The S&amp;amp;P also fell, declining 0.50 percent to 1,544.29.&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/WuhEQpWT9Xc" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 19 Mar 2013 21:06:01 Z</pubDate>
      <a10:updated>2013-03-19T18:54:26Z</a10:updated>
      <author>Jake L&amp;#39;Ecuyer</author>
      <nasdaq:tickers>ABC</nasdaq:tickers>
      <nasdaq:tickers>DSW</nasdaq:tickers>
      <nasdaq:tickers>NPSP</nasdaq:tickers>
      <nasdaq:tickers>WAC</nasdaq:tickers>
      <nasdaq:tickers>WAG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/midday-market-update-markets-turn-red-dsw-declines-on-downbeat-view-cm228627</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/midmorning-market-update-markets-turn-green-electronic-arts-ceo-steps-down-cm228542">
      <guid isPermaLink="false">228542</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rK66JQEH3IE/midmorning-market-update-markets-turn-green-electronic-arts-ceo-steps-down-cm228542</link>
      <category>Investing</category>
      <category>Commodities</category>
      <category>Economy</category>
      <category>International</category>
      <title>Mid-Morning Market Update: Markets Turn Green, Electronic Arts CEO Steps Down</title>
      <description>Following the market opening Tuesday, the Dow traded up 0.30 percent to 14,495.64 while the NASDAQ gained 0.29 percent to 3,247.08. The S&amp;amp;P also rose, gaining 0.22 percent to 1,555.49.&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/rK66JQEH3IE" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 19 Mar 2013 18:23:34 Z</pubDate>
      <a10:updated>2013-03-19T16:59:26Z</a10:updated>
      <author>Jake L&amp;#39;Ecuyer</author>
      <nasdaq:tickers>ABC</nasdaq:tickers>
      <nasdaq:tickers>CAH</nasdaq:tickers>
      <nasdaq:tickers>DSW</nasdaq:tickers>
      <nasdaq:tickers>LSCC</nasdaq:tickers>
      <nasdaq:tickers>NPSP</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/midmorning-market-update-markets-turn-green-electronic-arts-ceo-steps-down-cm228542</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/nps-pharma-incurs-wider-4q-loss-analyst-blog-cm220778">
      <guid isPermaLink="false">220778</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/odLnoBwqoxU/nps-pharma-incurs-wider-4q-loss-analyst-blog-cm220778</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>NPS Pharma Incurs Wider 4Q Loss  - Analyst Blog</title>
      <description>NPS Pharmaceuticals, Inc.  (  NPSP  ) reported fourth quarter 2012 net loss per share of 14 cents, wider than the Zacks Consensus Estimate of a loss of 9 cents and the year-ago loss of 10&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/odLnoBwqoxU" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 25 Feb 2013 20:00:01 Z</pubDate>
      <a10:updated>2013-02-25T16:34:33Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>LCI</nasdaq:tickers>
      <nasdaq:tickers>NPSP</nasdaq:tickers>
      <nasdaq:tickers>SBS</nasdaq:tickers>
      <nasdaq:tickers>SIGA</nasdaq:tickers>
      <nasdaq:tickers>UTHR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/nps-pharma-incurs-wider-4q-loss-analyst-blog-cm220778</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/benzinga-midday-market-update-cm182698">
      <guid isPermaLink="false">182698</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G-oj58sgRe8/benzinga-midday-market-update-cm182698</link>
      <category>Investing</category>
      <category>Commodities</category>
      <category>Earnings</category>
      <category>Economy</category>
      <category>International</category>
      <title>Benzinga Mid-Day Market Update</title>
      <description>Mid-way through trading Thursday, the Dow traded up 0.15 percent to 13,577.89 while the NASDAQ fell 0.11 percent to 3,100.68. The S&amp;amp;P also rose, increasing 0.14 percent to 1,462.94.  As&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/G-oj58sgRe8" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 18 Oct 2012 20:45:12 Z</pubDate>
      <a10:updated>2012-10-18T16:54:27Z</a10:updated>
      <author>Benzinga</author>
      <nasdaq:tickers>ALGN</nasdaq:tickers>
      <nasdaq:tickers>ISIS</nasdaq:tickers>
      <nasdaq:tickers>MLNX</nasdaq:tickers>
      <nasdaq:tickers>MNKD</nasdaq:tickers>
      <nasdaq:tickers>NPSP</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/benzinga-midday-market-update-cm182698</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/after-hours-most-active-for-oct-16-2012-intc-valep-qqq-ctl-f-vale-amd-orcl-s-npsp-infy-msft-cm182001">
      <guid isPermaLink="false">182001</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MShJ2w83qfY/after-hours-most-active-for-oct-16-2012-intc-valep-qqq-ctl-f-vale-amd-orcl-s-npsp-infy-msft-cm182001</link>
      <category>News Headlines</category>
      <category>After Hours Most Active</category>
      <title>After Hours Most Active for Oct 16, 2012 :  INTC, VALE/P, QQQ, CTL, F, VALE, AMD, ORCL, S, NPSP, INFY, MSFT</title>
      <description>The  NASDAQ 100 After Hours Indicator  is down -7.4 to 2,770.98. The total After hours volume is currently 35,221,946 shares traded.    The following are the   most active stocks for the after&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/MShJ2w83qfY" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 17 Oct 2012 00:40:00 Z</pubDate>
      <a10:updated>2012-10-16T21:00:37Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>AMD</nasdaq:tickers>
      <nasdaq:tickers>CTL</nasdaq:tickers>
      <nasdaq:tickers>F</nasdaq:tickers>
      <nasdaq:tickers>INFY</nasdaq:tickers>
      <nasdaq:tickers>INTC</nasdaq:tickers>
      <nasdaq:tickers>MSFT</nasdaq:tickers>
      <nasdaq:tickers>NPSP</nasdaq:tickers>
      <nasdaq:tickers>ORCL</nasdaq:tickers>
      <nasdaq:tickers>QQQ</nasdaq:tickers>
      <nasdaq:tickers>S</nasdaq:tickers>
      <nasdaq:tickers>VALE</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/after-hours-most-active-for-oct-16-2012-intc-valep-qqq-ctl-f-vale-amd-orcl-s-npsp-infy-msft-cm182001</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/premarket-most-active-for-oct-12-2012-bac-amd-s-jpm-wfc-bcs-clwr-asml-npsp-qqq-siri-aezs-cm181025">
      <guid isPermaLink="false">181025</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TOhBJWIxUCA/premarket-most-active-for-oct-12-2012-bac-amd-s-jpm-wfc-bcs-clwr-asml-npsp-qqq-siri-aezs-cm181025</link>
      <category>News Headlines</category>
      <category>Pre-market Most Active</category>
      <title>Pre-Market Most Active for Oct 12, 2012 :  BAC, AMD, S, JPM, WFC, BCS, CLWR, ASML, NPSP, QQQ, SIRI, AEZS</title>
      <description>The  NASDAQ 100 Pre-Market Indicator  is up 3.67 to 2,722.88. The total Pre-Market volume is currently 2,044,609 shares traded.    The following are the   most active stocks for the pre-market&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/TOhBJWIxUCA" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 12 Oct 2012 16:39:59 Z</pubDate>
      <a10:updated>2012-10-12T13:00:12Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>AEZS</nasdaq:tickers>
      <nasdaq:tickers>AMD</nasdaq:tickers>
      <nasdaq:tickers>ASML</nasdaq:tickers>
      <nasdaq:tickers>BAC</nasdaq:tickers>
      <nasdaq:tickers>BCS</nasdaq:tickers>
      <nasdaq:tickers>CLWR</nasdaq:tickers>
      <nasdaq:tickers>JPM</nasdaq:tickers>
      <nasdaq:tickers>NPSP</nasdaq:tickers>
      <nasdaq:tickers>QQQ</nasdaq:tickers>
      <nasdaq:tickers>S</nasdaq:tickers>
      <nasdaq:tickers>SIRI</nasdaq:tickers>
      <nasdaq:tickers>WFC</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/premarket-most-active-for-oct-12-2012-bac-amd-s-jpm-wfc-bcs-clwr-asml-npsp-qqq-siri-aezs-cm181025</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/bulls-want-to-stick-with-nps-pharma-cm178801">
      <guid isPermaLink="false">178801</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4nqGoPGZo2o/bulls-want-to-stick-with-nps-pharma-cm178801</link>
      <category>Investing</category>
      <category>Options</category>
      <title>Bulls want to stick with NPS Pharma</title>
      <description>NPS Pharmaceuticals has been on a one-way trip higher, and one investor wants to stay on the train.    optionMONSTER's Heat Seeker tracking system detected the purchase of about 2,000 October 9&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/4nqGoPGZo2o" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 03 Oct 2012 21:49:19 Z</pubDate>
      <a10:updated>2012-10-03T18:49:33Z</a10:updated>
      <author>David Russell</author>
      <nasdaq:tickers>NPSP</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/bulls-want-to-stick-with-nps-pharma-cm178801</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/options-ideas-24-healthcare-stocks-with-bullish-options-sentiment-cm79464">
      <guid isPermaLink="false">79464</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JzL4GNTcuHs/options-ideas-24-healthcare-stocks-with-bullish-options-sentiment-cm79464</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Options Ideas: 24 Healthcare Stocks With Bullish Options Sentiment</title>
      <description>Are you looking to boost your exposure to the healthcare sector? If so, this may be an interesting starting point for you own analysis.  To construct this list we looked for stocks with three&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/JzL4GNTcuHs" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 07 Jun 2011 21:15:59 Z</pubDate>
      <a10:updated>2011-06-07T17:40:55Z</a10:updated>
      <author>Kapitall</author>
      <nasdaq:tickers>ACOR</nasdaq:tickers>
      <nasdaq:tickers>ALNY</nasdaq:tickers>
      <nasdaq:tickers>ALXN</nasdaq:tickers>
      <nasdaq:tickers>AMAG</nasdaq:tickers>
      <nasdaq:tickers>GTXI</nasdaq:tickers>
      <nasdaq:tickers>KCI</nasdaq:tickers>
      <nasdaq:tickers>LNCR</nasdaq:tickers>
      <nasdaq:tickers>NPSP</nasdaq:tickers>
      <nasdaq:tickers>SHPGY</nasdaq:tickers>
      <nasdaq:tickers>VOLC</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/options-ideas-24-healthcare-stocks-with-bullish-options-sentiment-cm79464</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/top-6-stocks-for-june-cm77183">
      <guid isPermaLink="false">77183</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tnFzXDlUHck/top-6-stocks-for-june-cm77183</link>
      <category>Investing</category>
      <category>Stocks</category>
      <title>Top 6 Stocks for June</title>
      <description>Strong Earnings, Dividends and Technicals       Following a run to new highs in early April, stocks pulled back briefly, and then drove to new highs on May 2. But profit-taking, signs of a global&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/tnFzXDlUHck" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 24 May 2011 04:01:18 Z</pubDate>
      <a10:updated>2011-05-27T02:41:43Z</a10:updated>
      <author>Sam Collins</author>
      <nasdaq:tickers>ADI</nasdaq:tickers>
      <nasdaq:tickers>AUY</nasdaq:tickers>
      <nasdaq:tickers>NPSP</nasdaq:tickers>
      <nasdaq:tickers>UGI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/top-6-stocks-for-june-cm77183</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/the-top-20-most-undervalued-healthcare-stocks-by-target-price-cm53287">
      <guid isPermaLink="false">53287</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WExLCjdRzvk/the-top-20-most-undervalued-healthcare-stocks-by-target-price-cm53287</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>The Top 20 Most Undervalued Healthcare Stocks By Target Price</title>
      <description>Compiled by Luis Gonzalez:  The following is a list of the most undervalued healthcare stocks, when comparing the current price against the average analyst target price (used as a proxy for fair&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/WExLCjdRzvk" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 15 Jan 2011 01:44:38 Z</pubDate>
      <a10:updated>2011-01-14T20:44:40Z</a10:updated>
      <author>Kapitall</author>
      <nasdaq:tickers>ABT</nasdaq:tickers>
      <nasdaq:tickers>ACOR</nasdaq:tickers>
      <nasdaq:tickers>AMMD</nasdaq:tickers>
      <nasdaq:tickers>BMTI</nasdaq:tickers>
      <nasdaq:tickers>CMED</nasdaq:tickers>
      <nasdaq:tickers>CORT</nasdaq:tickers>
      <nasdaq:tickers>EURX</nasdaq:tickers>
      <nasdaq:tickers>HALO</nasdaq:tickers>
      <nasdaq:tickers>HGSI</nasdaq:tickers>
      <nasdaq:tickers>HWAY</nasdaq:tickers>
      <nasdaq:tickers>INCY</nasdaq:tickers>
      <nasdaq:tickers>ISPH</nasdaq:tickers>
      <nasdaq:tickers>MR</nasdaq:tickers>
      <nasdaq:tickers>NPSP</nasdaq:tickers>
      <nasdaq:tickers>OFIX</nasdaq:tickers>
      <nasdaq:tickers>OPTR</nasdaq:tickers>
      <nasdaq:tickers>PBTH</nasdaq:tickers>
      <nasdaq:tickers>THOR</nasdaq:tickers>
      <nasdaq:tickers>WCRX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/the-top-20-most-undervalued-healthcare-stocks-by-target-price-cm53287</feedburner:origLink></item>
  </channel>
</rss>
